Trial Outcomes & Findings for Flexitouch Compression System for Venous Stasis Ulcer (NCT NCT00534937)
NCT ID: NCT00534937
Last Updated: 2013-03-01
Results Overview
Number of subjects that experience complete healing of the study venous stasis ulcer during the 12 week treatment period.
TERMINATED
PHASE4
89 participants
12 weeks
2013-03-01
Participant Flow
Recruitment occurred at medical clinics. The first subject was enrolled in November 2007. The subjects were recruited from current patient populations and new patients coming to the clinic. Advertisement materials were used to increase enrollment with little success.
Participant milestones
| Measure |
Standard Compression
Patients in this arm will receive current standard of care (once-weekly short-stretch compression wrapping).
|
Flexitouch
Patients in this arm will receive once-a-week short stretch compression wrapping AND once daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Overall Study
STARTED
|
42
|
47
|
|
Overall Study
COMPLETED
|
34
|
35
|
|
Overall Study
NOT COMPLETED
|
8
|
12
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Flexitouch Compression System for Venous Stasis Ulcer
Baseline characteristics by cohort
| Measure |
Standard Compression
n=42 Participants
Patients in this arm will receive current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=47 Participants
Patients in this arm will receive once-a-week short stretch compression wrapping AND once daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
Total
n=89 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age Continuous
|
56.6 years
STANDARD_DEVIATION 14.3 • n=5 Participants
|
57.4 years
STANDARD_DEVIATION 16.1 • n=7 Participants
|
57.0 years
STANDARD_DEVIATION 15.2 • n=5 Participants
|
|
Sex/Gender, Customized
Female
|
11 participants
n=5 Participants
|
12 participants
n=7 Participants
|
23 participants
n=5 Participants
|
|
Sex/Gender, Customized
Male
|
28 participants
n=5 Participants
|
33 participants
n=7 Participants
|
61 participants
n=5 Participants
|
|
Sex/Gender, Customized
Unknown
|
3 participants
n=5 Participants
|
2 participants
n=7 Participants
|
5 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: 12 weeksNumber of subjects that experience complete healing of the study venous stasis ulcer during the 12 week treatment period.
Outcome measures
| Measure |
Standard Compression
n=42 Participants
Patients in this arm received current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=47 Participants
Patients in this arm received once-a-week short stretch compression wrapping AND once-daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Complete Healing Rate of Venous Stasis Ulcers
|
19 participants
|
20 participants
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: The participants are those that didn't achieve complete wound healing after 12 weeks of treatment. The change from screening to week 12 in wound surface area is reported.
Change in wound surface area in cm2 from the initial screening to week 12 for all subject who did not completely healed before or at the 12 week visit.
Outcome measures
| Measure |
Standard Compression
n=17 Participants
Patients in this arm received current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=15 Participants
Patients in this arm received once-a-week short stretch compression wrapping AND once-daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Change in Wound Surface Area for Non Healed Subject at 12 Weeks.
|
-8.1 cm2
Standard Deviation 9.8
|
-9.6 cm2
Standard Deviation 11.3
|
SECONDARY outcome
Timeframe: 12 weeksPopulation: Number of participants who completed 12 weeks of treatment without healing. Also limb volume measures must have been present.
Outcome measures
| Measure |
Standard Compression
n=17 Participants
Patients in this arm received current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=16 Participants
Patients in this arm received once-a-week short stretch compression wrapping AND once-daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Percentage Change in Volume of the Affected Limb (-Reduction; +Increase)
|
-2.9 percentage of change
Standard Deviation 34.1
|
-7 percentage of change
Standard Deviation 29.1
|
SECONDARY outcome
Timeframe: Baseline to 12 weeksPopulation: Time to healing can only evaluate the patients that showed healing during the 12 week study therefore the number may not be consistent with other numbers.
Only 2 time points so no calculation details are necessary. The change is calculated as the later time point minus the earlier time point (e.g., 12 weeks minus baseline).
Outcome measures
| Measure |
Standard Compression
n=19 Participants
Patients in this arm received current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=20 Participants
Patients in this arm received once-a-week short stretch compression wrapping AND once-daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Time to Healing of the Venous Stasis Ulcer
|
37 days
Standard Deviation 24.9
|
43.9 days
Standard Deviation 22.3
|
Adverse Events
Standard Compression
Flexitouch
Serious adverse events
| Measure |
Standard Compression
n=42 participants at risk
Patients in this arm will receive current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=47 participants at risk
Patients in this arm will receive once-a-week short stretch compression wrapping AND once daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Infections and infestations
Cellulitis / Infection of lower extremity
|
7.1%
3/42 • Number of events 3 • AEs were collected form 2007 to 2010 at the time of study closure.
|
0.00%
0/47 • AEs were collected form 2007 to 2010 at the time of study closure.
|
Other adverse events
| Measure |
Standard Compression
n=42 participants at risk
Patients in this arm will receive current standard of care (once weekly short-stretch compression wrapping).
|
Flexitouch
n=47 participants at risk
Patients in this arm will receive once-a-week short stretch compression wrapping AND once daily Flexitouch pump application (including Flexitouch application once-a-week in the clinic setting).
|
|---|---|---|
|
Infections and infestations
Cellulitis / Infection of lower extremity
|
19.0%
8/42 • Number of events 8 • AEs were collected form 2007 to 2010 at the time of study closure.
|
12.8%
6/47 • Number of events 6 • AEs were collected form 2007 to 2010 at the time of study closure.
|
Additional Information
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place
Restriction type: LTE60